SELLAS Life Sciences (SLS) Income from Discontinued Operations (2011 - 2017)
SELLAS Life Sciences (SLS) reported Income from Discontinued Operations of $118,000 for Q3 2017, compared with -$2.59 million a year earlier.
Powered by 
Analysis
SELLAS Life Sciences (SLS) Income from Discontinued Operations (2011 - 2017) Analysis & Trends
Over the twelve months ended Sep 30, 2017, SELLAS Life Sciences' Income from Discontinued Operations came in at -$14.2 million; for FY2016, it came in at -$12.45 million.
- By year, Income from Discontinued Operations came in at $24.95 million in FY2015, -$8.32 million in FY2014, $5.35 million in FY2013 and -$1.64 million in FY2012.
- The Q3 2017 figure ranks as the highest quarterly Income from Discontinued Operations since Q4 2015.
- Per Business Quant data, the three quarters before Q3 2017 came in at -$1.3 million (Q2 2017), -$9.44 million (Q1 2017) and -$3.58 million (Q4 2016).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 8.00 Mn |
| 10 | SELLAS Life Sciences | 2.37 Bn | 2.37 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2017 | 118,000.00 |
| Jun 30, 2017 | -1.30 Mn |
| Mar 31, 2017 | -9.44 Mn |
| Dec 31, 2016 | -3.58 Mn |
| Sep 30, 2016 | -2.59 Mn |
| Jun 30, 2016 | -2.89 Mn |
| Mar 31, 2016 | -3.39 Mn |
| Dec 31, 2015 | 41.02 Mn |
| Sep 30, 2015 | -11.67 Mn |
| Jun 30, 2015 | -2.19 Mn |
| Mar 31, 2015 | -2.23 Mn |
| Dec 31, 2014 | -1.69 Mn |
| Sep 30, 2014 | -2.64 Mn |
| Dec 31, 2013 | 5.35 Mn |
| Jun 30, 2012 | -423,000.00 |
| Mar 31, 2012 | -1.22 Mn |
| Dec 31, 2011 | -2.18 Mn |
| Sep 30, 2011 | -1.64 Mn |
| Jun 30, 2011 | -2.16 Mn |
API Access
SELLAS Life Sciences Income from Discontinued Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=SLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-discontinued-operations", "ticker": "SLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=SLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();